HIV Cure Breakthrough: First Widespread Treatment in Children
Children Offer New Hope in teh Quest for an HIV cure
Table of Contents
Early treatment in children may unlock a natural ability to suppress the virus, potentially leading to a cure.
For decades, the scientific community has been on a relentless pursuit of a cure for HIV.While antiretroviral therapy (ART) has been remarkably accomplished in stopping the virus from replicating and allowing individuals to live long, healthy lives, it requires lifelong adherence. Though, a growing body of evidence suggests that children, especially those treated early in life, may hold a key to achieving a functional cure for HIV.
The Unexpected remission
Researchers like Goulder and his colleagues have observed a phenomenon that defies conventional understanding of HIV treatment. In a study tracking children on ART, five children stopped attending clinic appointments to collect their medication.Months later, when eventually located, these children were found to be in perfect health, wiht undetectable viral loads – a stark contrast to the expected rapid rebound of HIV within weeks of stopping treatment.
“Instead of their viral loads being through the roof,they were undetectable,” stated Goulder. “And normally HIV rebounds within two or three weeks.”
Further research, published last year, revealed that these five children remained in remission, some for provided that 17 months, without regular antiretroviral medication. This groundbreaking observation has ignited hope that the first widespread success in curing HIV might emerge not from adult treatments, but from understanding and harnessing the unique immunological capabilities of children.
Children’s Immune Systems: A Promising Frontier
The International AIDS Society conference in Kigali, Rwanda, recently highlighted new findings supporting this optimistic outlook.Alfredo Tagarro, a pediatrician at the Infanta Sofia University Hospital in Madrid, presented a study indicating that approximately 5 percent of HIV-infected children who receive antiretrovirals within the first six months of life ultimately suppress their HIV viral reservoir to negligible levels.
“Children have special immunological features which makes it more likely that we will develop an HIV cure for them before other populations,” Tagarro explained.
This sentiment was echoed by Mark Cotton, director of the children’s infectious diseases clinical research unit at the University of Stellenbosch, Cape Town. He emphasized the advantages of targeting children for cure research.
“kids have a much more dynamic immune system,” Cotton noted. “They also don’t have any additional issues like high blood pressure or kidney problems. it makes them a better target, initially, for a cure.”
Leaving Adults Behind, Focusing on Children
historically, children with HIV have been underserved in the search for a cure. While ten adults are believed to have been cured as 2007 through complex and high-risk stem cell transplants for blood cancers, this procedure is not a viable strategy for the general HIV-positive population due to its inherent dangers.
Instead, pediatricians like Goulder have increasingly focused on the observation that a small subset of children, after early ART initiation, appear to develop the ability to control HIV with their immune systems alone. This phenomenon was first noted in isolated case studies, such as the “Mississippi baby,” who controlled the virus for over two years without medication, and a South african child who has remained in remission for more than a decade. Cotton estimates that between 10 and 20 percent of all HIV-infected children could potentially control the virus for extended periods after discontinuing antiretrovirals.
This emerging understanding of children’s unique immunological responses to early HIV intervention offers a tangible and hopeful path forward in the decades-long quest for an HIV cure.